A defense contractor with 83% net profit growth, a €17 billion order backlog, and unanimous “buy” ratings from ten analysts – yet its shares have shed more than 60% since January. The Czechoslovak Group (CSG) presents a textbook case of operational strength colliding with market skepticism. Two distinct overhangs are to blame: a bitter legal battle with a minority shareholder and a high-profile Ukrainian partnership that carries no price tag.
The Courtroom Drag
Petr Kratochvíl, who holds roughly 10% of CSG Land Systems CZ and 9% of the MSM Group, is demanding €1.4 billion for his stakes. CSG has countered with less than one-tenth of that figure – a gap of around 31 billion Czech crowns that has frozen negotiations and landed the dispute in courts in both the Czech Republic and Slovakia. Kratochvíl was removed as chairman in March over conflict-of-interest concerns, and he is now challenging both the valuation of his holdings and the legality of internal share transfers. For investors, this uncertainty has become a stubborn drag on sentiment, one that even record operational metrics cannot offset.
A Ukraine Pact Without a Price
The company’s other headline story arrived from Kyiv last week: a licensing partnership with Ukrainian Armor to produce NATO-standard artillery rounds. Under the deal, 100,000 shells in caliber 155 mm and 50,000 in 105 mm will roll off Ukrainian production lines each year. Yet the announcement contained no contract value, no delivery schedule, and no clarity on CSG’s financial contribution. That lack of hard numbers has left the market unimpressed. Ukrainian Armor is also developing unmanned ground vehicles capable of hauling 1,000 kilograms of cargo into risk zones, but CSG’s involvement in that robotics program remains unconfirmed.
Operational Firepower
Away from the courtroom and the press release, CSG’s underlying business is firing on all cylinders. First-quarter revenue reached €1.544 billion, while operating EBIT climbed 8.7% to €372 million. Net profit surged 83% year-on-year, and the operating margin landed squarely within the 24–25% target range. Management affirmed its full-year outlook of €7.4–€7.6 billion in revenue.
Should investors sell immediately? Or is it worth buying CSG?
The ammunition division is running at full tilt: production capacity hit 800,000 large-caliber rounds in the first quarter. By year-end CSG expects to manufacture 850,000 new rounds in-house, plus another 400,000 refurbished shells. Looking further ahead, the company aims to lift total heavy-caliber output to 850,000 rounds annually by the end of 2026, up from 550,000 in 2025.
Expanding the Supply Chain
Recent weeks have also seen CSG tighten its grip on the ammunition supply chain. In early June, subsidiary STALUNA TRADE disclosed a nearly 10% voting stake in Alzchem Group, a German producer of nitroguanidine – a key ingredient for propellants and munitions. Additional financial instruments give CSG exposure to a further 10% of Alzchem’s voting rights. The same week, the group signed two contracts for mechanical and electronic fuses for large-caliber ammunition, valued in the high double-digit millions. Delivery to European NATO clients begins this year. The electronic fuses will be produced by Fuchs Electronics Europe, a newly formed joint venture with South Africa’s Reunert based in Slovakia.
Technicals Align with Skepticism
CSG’s stock last changed hands at around €14.34–€14.37, a hair above its 52-week low of €13.65. The relative strength index (RSI) of 29 signals deeply oversold conditions, and the shares trade more than 24% below their 50-day moving average. Yet even those technical signals have failed to lure buyers while the governance cloud persists. The average analyst price target stands at €32.05 – more than double the current level – but the gap between valuation and price reflects a market demanding resolution before any rerating.
What Could Break the Logjam
Investors are watching two potential catalysts. First, any first-instance court ruling from Prague or Bratislava in the Kratochvíl dispute could shift sentiment abruptly, for better or worse. Second, the half-year results due on August 7 (the quiet period begins July 8) will need to show concrete new orders that give financial weight to the Ukrainian partnership. Until then, CSG’s extraordinary operational momentum is being held hostage by a feud and a handshake.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from June 10 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 10.
CSG: Buy or sell? Read more here...
